Home » Archive by Category

Xconomy

BioNano Raises $53M to Identify “Structural Variations” in Genome

November 20, 2014 – 5:44 pm | Edit Post

San Diego-based BioNano Genomics, which has taken a fundamentally different approach to analyzing the genome, says today it has closed on $53 million in Series C financing to expand its…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: Gilead, Juno, Hutch, Fibrogen & More

November 20, 2014 – 2:21 pm | Edit Post

Snow? What snow? The only thing piling up at astonishing rates on the West Coast this week is biotech news. Up in Seattle, the Fred Hutchinson Cancer Research Center has unveiled its new president,…

[[Click headline to continue reading.]]

AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

September 3, 2014 – 4:56 am | Edit Post
AbbVie Plunks Down $275M Upfront for Infinity’s Blood Cancer Drug

It’s been a topsy-turvy few years for Infinity Pharmaceuticals. The Cambridge, MA-based company is well behind a few others, whose rival blood cancer drugs that have already made it to market, and…

[[Click headline to continue reading.]]

Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

September 2, 2014 – 6:37 pm | Edit Post
Feds Provide Funding, Expertise to Advance ZMapp Drug for Ebola

The U.S. Department of Health and Human Services said today it would provide its expertise and as much as $42.3 million to help San Diego-based Mapp Biopharmaceutical accelerate development and…

[[Click headline to continue reading.]]

Which Countries Excel in Creating New Drugs? It’s Complicated

September 2, 2014 – 12:00 am | Edit Post
Which Countries Excel in Creating New Drugs? It’s Complicated

A lot has been written lately about innovation, or the lack thereof, in the world of biopharma. One question that often gets asked: which countries lead the way in creating new medicines? Many people…

[[Click headline to continue reading.]]

Mapp Bio Steps onto Global Stage as Ebola “Hot Zone” Gets Hotter

August 28, 2014 – 9:01 pm | Edit Post
Mapp Bio Steps onto Global Stage as Ebola “Hot Zone” Gets Hotter

The “hot zone” in West Africa that has become the worst Ebola outbreak in history is now a full-blown global health crisis—and it is expected to continue into 2015. That is the consensus of…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More

August 28, 2014 – 11:36 am | Edit Post
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More

Lots of news this week up and down the coast and up and down the biotech food chain. We’ve got a new twist (or fold, if you prefer) on academic Ebola research at the University of Washington,…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More

August 28, 2014 – 11:36 am | Edit Post
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More

Lots of news this week up and down the coast and up and down the biotech food chain. We’ve got a new twist (or fold, if you prefer) on academic Ebola research at the University of Washington,…

[[Click headline to continue reading.]]

AirStrip Raises $25M to Expand into Home Health, Foreign Markets

August 27, 2014 – 7:34 am | Edit Post
AirStrip Raises $25M to Expand into Home Health, Foreign Markets

AirStrip, a San Antonio, TX-based company integrating mobile health and IT technologies, has raised $25 million in a strategic funding round that includes new and existing investors. In a statement,…

[[Click headline to continue reading.]]

AirStrip Raises $25M to Expand into Home Health, Foreign Markets

August 27, 2014 – 7:34 am | Edit Post
AirStrip Raises $25M to Expand into Home Health, Foreign Markets

AirStrip, a San Antonio, TX-based company integrating mobile health and IT technologies, has raised $25 million in a strategic funding round that includes new and existing investors. In a statement,…

[[Click headline to continue reading.]]